107 related articles for article (PubMed ID: 9286051)
1. Nasal immunization with group B streptococci can induce high levels of specific IgA antibodies in cervicovaginal secretions of mice.
Hordnes K; Tynning T; Brown TA; Haneberg B; Jonsson R
Vaccine; 1997 Aug; 15(11):1244-51. PubMed ID: 9286051
[TBL] [Abstract][Full Text] [Related]
2. Systemic and mucosal antibody responses to group B streptococci following immunization of the colonic-rectal mucosa.
Hordnes K; Digranes A; Haugen IL; Helland DE; Ulstein M; Jonsson R; Haneberg B
J Reprod Immunol; 1995 Mar; 28(3):247-62. PubMed ID: 7473434
[TBL] [Abstract][Full Text] [Related]
3. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
Infect Immun; 2000 Oct; 68(10):5749-55. PubMed ID: 10992481
[TBL] [Abstract][Full Text] [Related]
4. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
[TBL] [Abstract][Full Text] [Related]
5. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
[TBL] [Abstract][Full Text] [Related]
6. Colonization in the rectum and uterine cervix with group B streptococci may induce specific antibody responses in cervical secretions of pregnant women.
Hordnes K; Tynning T; Kvam AI; Jonsson R; Haneberg B
Infect Immun; 1996 May; 64(5):1643-52. PubMed ID: 8613373
[TBL] [Abstract][Full Text] [Related]
7. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R.
Hordnes K; Tynning T; Kvam AI; Bevanger L; Brown TA; Jonsson R; Haneberg B
Scand J Immunol; 1998 Feb; 47(2):179-88. PubMed ID: 9496695
[TBL] [Abstract][Full Text] [Related]
8. Intranasal immunization with GBS surface protein Sip and ScpB induces specific mucosal and systemic immune responses in mice.
Xue G; Yu L; Li S; Shen X
FEMS Immunol Med Microbiol; 2010 Mar; 58(2):202-10. PubMed ID: 19912341
[TBL] [Abstract][Full Text] [Related]
9. Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Wallerström G; Holmgren J
Vaccine; 2001 May; 19(25-26):3360-8. PubMed ID: 11348699
[TBL] [Abstract][Full Text] [Related]
10. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.
Wu HY; Russell MW
Infect Immun; 1993 Jan; 61(1):314-22. PubMed ID: 8418053
[TBL] [Abstract][Full Text] [Related]
11. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
Price GA; Russell MW; Cornelissen CN
Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481
[TBL] [Abstract][Full Text] [Related]
12. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
[TBL] [Abstract][Full Text] [Related]
13. Intranasal immunization with lipoteichoic acid and cholera toxin evokes specific pharyngeal IgA and systemic IgG responses and inhibits streptococcal adherence to pharyngeal epithelial cells in mice.
Yokoyama Y; Harabuchi Y
Int J Pediatr Otorhinolaryngol; 2002 May; 63(3):235-41. PubMed ID: 11997159
[TBL] [Abstract][Full Text] [Related]
14. Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
Infect Immun; 2001 Jan; 69(1):297-306. PubMed ID: 11119518
[TBL] [Abstract][Full Text] [Related]
15. A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin.
Berstad AK; Holst J; Møgster B; Haugen IL; Haneberg B
Vaccine; 1997; 15(12-13):1473-8. PubMed ID: 9302763
[TBL] [Abstract][Full Text] [Related]
16. Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination.
Eriksson K; Quiding-Järbrink M; Osek J; Möller A; Björk S; Holmgren J; Czerkinsky C
Infect Immun; 1998 Dec; 66(12):5889-96. PubMed ID: 9826370
[TBL] [Abstract][Full Text] [Related]
17. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.
Wu HY; Russell MW
Vaccine; 1998; 16(2-3):286-92. PubMed ID: 9607044
[TBL] [Abstract][Full Text] [Related]
18. Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection.
Larsson C; Holmgren J; Lindahl G; Bergquist C
Infect Immun; 2004 Feb; 72(2):1184-7. PubMed ID: 14742572
[TBL] [Abstract][Full Text] [Related]
19. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces.
Haneberg B; Kendall D; Amerongen HM; Apter FM; Kraehenbuhl JP; Neutra MR
Infect Immun; 1994 Jan; 62(1):15-23. PubMed ID: 8262621
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
Siadat-Pajouh M; Cai L
Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
